EN DE

Hangzhou Haoyue Personal Care Co (605009) Fair Value & Analysis

Consumer Defensive · CN · Market cap 5.0B CNY

HH Hangzhou Haoyue Personal Care Co 605009 · SHG
Price¥24.06
Fair Value¥22.65
Upside-5.9%
Quality57/100
Watch Hangzhou Haoyue Personal Care Co for free, get notified when fair value or trend changes. Watch for free
Expensive Growth
Thin margins · 5.9% net margin
Low debt · negative free cash flow
Mixed vs. peers (5/12)
Narrow moat 41/100
Evidence: High Range ¥16.99 – ¥28.32 Share as image

Fair value as of: Jul 12, 2026

From 16 valuation models · updated 29 days ago

Fair value updated Jul 12, 2026, revised from ¥22.96 to ¥22.65 (−1.4%) since Jun 24, 2026. Share price +0.2% over the past month.

A solid business, currently priced close to our fair value.

What matters now

  • The price sits close to our fair value, market and models broadly agree here, little valuation tension.
  • Our model range runs from ¥16.99 (bear) to ¥28.32 (bull), base ¥22.65. The closer the price sits to the lower half, the larger the margin of safety.
  • Quality 57/100 (solid quality) with high evidence: the data supports the verdict.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

¥70.38 ¥21.67 Fair Value ¥22.65 Feb 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 12, 2026.

How to read this chart

60‑month range ¥21.67 – ¥70.38 · fair‑value band ¥16.99 – ¥28.32 · the ¥24.06 price screens above the ¥22.65 fair value. Dashed = 300-day average. As of Jul 12, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Hangzhou Haoyue Personal Care Co (605009) currently trades at ¥24.06, while our model-based Fair Value estimate is ¥22.65, implying the stock looks roughly 5.9% fairly valued today. The Quality Score stands at 57/100 (solid quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).

Over the trailing twelve months, Hangzhou Haoyue Personal Care Co generated revenue of 3.8B CNY at a net margin of 5.9%. Revenue grew 7.0% year over year. It earns a return on equity of 6.5%. The balance sheet holds a net cash position of 1.0B CNY. Fundamentals as of Jul 12, 2026

Our scenario range runs from ¥16.99 (bear case) to ¥28.32 (bull case); at ¥24.06, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 50% below its 52-week high and 6% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -26% fair-value upside, at -6%, 605009 screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model BearBaseBull Evidence
Highest evidence
Residual Income ¥12.69 ¥13.28 ¥13.83 76
ROIC Compounder ¥10.52 ¥12.05 ¥13.37 72
Gordon GGM ¥5.56 ¥11.07 ¥16.76 70
All 16 models by family
Earnings-Based
Graham-Dodd ¥7.34 ¥43.37 ¥60.41 54
Lynch FV ¥12.32 ¥17.59 ¥22.87 50
PEG = 1.0 ¥12.32 ¥17.59 ¥22.87 46
EPV ¥10.52 ¥12.05 ¥13.37 59
Dividend Discount
Gordon GGM ¥5.56 ¥11.07 ¥16.76 70
DDM Multi-Stage ¥5.56 ¥9.57 ¥11.69 61
Multiples
P/E Multiple ¥16.99 ¥22.65 ¥28.32 63
P/S Multiple ¥13.75 ¥18.34 ¥22.92 58
P/B Multiple ¥13.75 ¥18.34 ¥22.92 55
EV/EBIT ¥18.76 ¥24.72 ¥30.69 53
EV/EBITDA ¥22.77 ¥30.07 ¥37.38 54
EV/Revenue ¥13.63 ¥19.11 ¥24.58 43
Asset-Based
NCAV (Graham) ¥7.94 ¥10.64 ¥15.88 50
Economic Profit
Residual Income ¥12.69 ¥13.28 ¥13.83 76
ROIC Compounder ¥10.52 ¥12.05 ¥13.37 72
Growth Earnings
Growth-Adj P/E ¥18.02 ¥25.74 ¥33.46 68

Widest divergence: Growth Earnings (¥25.74) versus Dividend Discount (¥9.57). Highest evidence: Residual Income (76).

Key figures & financial health

Revenue (TTM) 3.8B CNY
Revenue growth (YoY) +7.0%
Net margin 5.9%
Return on equity 6.5%
Free cash flow −325M CNY FY2025
P/E ratio 22.3
More key figures
Operating margin 11.1%
EPS (TTM) ¥1.05
EPS growth (YoY) -7.1%
Net cash 1.0B CNY FY2024

Figures from reported company fundamentals · as of Jul 12, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 57/100

Of which business quality 56 · Market factors (momentum, volatility) 31

Profitability 40
Margins and returns on capital today
Quality Growth 61
Are margins and returns improving?
Cashflow 17
Earnings quality: real cash, not paper profit
Fin. Strength 85
Balance sheet, leverage, solvency risk
Investment 57
Disciplined investing over empire-building
Low Volatility 84
Calm price path (market factor)
Momentum 13
Price trend over the last 3–12 months (market factor)
52W Momentum 3
Distance to the 52-week high (market factor)
Net Issuance 88
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Hangzhou Haoyue Personal Care Co., Ltd. research, develops, manufactures, and sells women, young, and adult health care products under the haoyue brand name in China. The company sells baby diapers, including tape, and pull-up diaper, and wet tissue; adult diapers; nursing pad; and sanitary napkins products. Hangzhou Haoyue Personal Care Co., Ltd.

Full company description

Hangzhou Haoyue Personal Care Co., Ltd. research, develops, manufactures, and sells women, young, and adult health care products under the haoyue brand name in China. The company sells baby diapers, including tape, and pull-up diaper, and wet tissue; adult diapers; nursing pad; and sanitary napkins products. Hangzhou Haoyue Personal Care Co., Ltd. was founded in 1992 and is headquartered in Hangzhou, China.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Hangzhou Haoyue Personal Care Co reported revenue of ¥3.8B in FY2025 versus ¥2.5B in FY2021, a compound +11.1%/yr. Reported net income was ¥232M in FY2025, compounding −10.6%/yr from FY2021.

Growth Quality 43/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Latest Revenue (FY 2025)
3.8B CNY
Latest YoY
+28.2%
Avg. growth/yr (3Y)
+10.3%
Avg. growth/yr (5Y)
+7.7%
Avg. growth/yr (9Y)
+26.1%
Revenue +11.1%/yr
FY21 ¥2.5B
FY22 ¥2.8B
FY23 ¥2.8B
FY24 ¥2.9B
FY25 ¥3.8B
Net income −10.6%/yr
FY21 ¥363M
FY22 ¥423M
FY23 ¥439M
FY24 ¥388M
FY25 ¥232M

Watch 605009: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Hangzhou Haoyue Personal Care Co Fair Value". https://www.fairvalue-calculator.com/stock/605009

Peer Group

Household & Personal Products · 244 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 57 · Below median
Fair Value upside −6% · Below median
Return on equity (TTM) 7% · Below median
Return on assets 3% · Above median
Net margin (TTM) 6% · Above median
Operating margin (TTM) 11% · Above median
Revenue growth 7% · Above median
Debt / equity 0.07× · Higher than median

Valuation Multiples vs Household & Personal Products median · lower = cheaper

P/E (TTM) 22.3× · Pricier than median
P/B 1.48× · Cheaper than median
P/S (TTM) 1.32× · Pricier than median
EV/EBITDA 10.8× · Pricier than median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 25 · sector 28
FUTURE 35 · sector 4
PAST 26 · sector 26
HEALTH 97 · sector 98
DIVIDEND 0 · sector 50

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Household & Personal Products stocks, each showing price versus our Fair Value estimate (as of Jul 12, 2026).

Stock Price Fair Value vs Fair Value
The Procter & Gamble Company PG $146.80 $108.16 -26%
Unilever PLC ULN 1,080 MXN 1,273 MXN +18%
Hindustan Unilever Limited HINDUNILVR ₹2,144 ₹1,000 -53%
Essity AB ESSITYA kr 279.00 kr 250.02 -10%
Godrej Consumer Products Limited GODREJCP ₹1,088 ₹367.64 -66%
Marico Limited MARICO ₹846.75 ₹233.05 -72%
APR Co 278470 375,000 KRW 151,222 KRW -60%
Dabur India Limited DABUR ₹429.45 ₹181.60 -58%
Kimberly-Clark de México, S. A. B. de C. V., KIMBERA 38.07 MXN 50.09 MXN +32%
PT Unilever Indonesia Tbk UNVR 1,730 IDR 1,934 IDR +12%

Compare Hangzhou Haoyue Personal Care Co with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Hangzhou Haoyue Personal Care Co (605009) overvalued or undervalued?
As of Jul 12, 2026, our model estimates a fair value of ¥22.65 versus a price of ¥24.06, about −6% (fairly valued).
What is the fair value of 605009?
Our model-based fair value for Hangzhou Haoyue Personal Care Co is ¥22.65 (as of Jul 12, 2026), built from audited fundamentals. The current price is ¥24.06.
What is the quality score of 605009?
Hangzhou Haoyue Personal Care Co has a Quality Score of 57/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Hangzhou Haoyue Personal Care Co (605009)?
Hangzhou Haoyue Personal Care Co reported trailing-twelve-month revenue of about 3.8B CNY (latest available figure, as of Jul 12, 2026).
What is the net profit margin of 605009?
The net profit margin of Hangzhou Haoyue Personal Care Co is about 5.9%, meaning it keeps roughly 5.9% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Hangzhou Haoyue Personal Care Co and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.